Hunter Syndrome Treatment Market Size, Share, Analysis, Trends, Growth Report 2032

Hunter Syndrome Treatment Market

Hunter Syndrome Treatment Market by Treatment (Hematopoietic Stem Cell Transplant (HSCT), Enzyme Replacement Therapy (ERT), and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 - 2026

Category: Healthcare Report Format : PDF Pages: 207 Report Code: ZMR-5333 Published Date: Jun-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 1175.86 Million USD 2,331.03 Million 7.9% 2023

Hunter Syndrome Treatment Market

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Hunter Syndrome Treatment Market, 2016 - 2026, (USD Million)
    • 2.2. Hunter Syndrome Treatment Market: Snapshot
  • Chapter 3. Global Hunter Syndrome Treatment Market – Industry Analysis
    • 3.1. Hunter Syndrome Treatment Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Expected approval of new therapies
      • 3.2.2. Growing research and development activities
    • 3.3. Restraints
      • 3.3.1. Lack of awareness
      • 3.3.2. High cost
    • 3.4. Opportunity
      • 3.4.1. Increasing cullaboration
      • 3.4.2. Technological advancements
    • 3.5. Porter’s Five Forces Analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis by treatment segment
      • 3.6.2. Market attractiveness analysis by regional segment
  • Chapter 4. Global Hunter Syndrome Treatment Market - Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global hunter syndrome treatment market: company market share analysis, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New indication launches
      • 4.2.3. Agreements, partnerships, cullaborations and joint ventures
      • 4.2.4. Research and development and regional expansion
  • Chapter 5. Global Hunter Syndrome Treatment Market – Treatment Segment Analysis
    • 5.1. Global hunter syndrome treatment market overview: by treatment
      • 5.1.1. Global hunter syndrome treatment market revenue share, by treatment, 2019 and 2026
    • 5.2. Hematopoietic Stem Cell Transplant (HSCT)
      • 5.2.1. Global hunter syndrome treatment market by Hematopoietic Stem Cell Transplant (HSCT), 2016 - 2026(USD Million)
    • 5.3. Enzyme Replacement Therapy (ERT)
      • 5.3.1. Global hunter syndrome treatment market by Enzyme Replacement Therapy (ERT), 2016 - 2026(USD Million)
    • 5.4. Others
      • 5.4.1. Global hunter syndrome treatment market by Others, 2016 - 2026(USD Million)
  • Chapter 6. Global Hunter Syndrome Treatment Market - Regional Analysis
    • 6.1. Global hunter syndrome treatment market overview: by region
      • 6.1.1. Global hunter syndrome treatment market revenue share, by region, 2019 and 2026
    • 6.2. North America
      • 6.2.1. North America hunter syndrome treatment market, by country, 2016 - 2026(USD Million)
      • 6.2.2. North America hunter syndrome treatment market revenue, by treatment, 2016 - 2026(USD Million)
      • 6.2.3. The U.S.
        • 6.2.3.1. The U.S. hunter syndrome treatment market revenue, by treatment, 2016 - 2026(USD Million)
      • 6.2.4. Rest of North America
        • 6.2.4.1. Rest of North America hunter syndrome treatment market revenue, by treatment, 2016 - 2026(USD Million)
    • 6.3. Europe
      • 6.3.1. Europe hunter syndrome treatment market, by country, 2016 - 2026(USD Million)
      • 6.3.2. Europe hunter syndrome treatment market revenue, by treatment, 2016 - 2026(USD Million)
      • 6.3.3. U.K.
        • 6.3.3.1. U.K. hunter syndrome treatment market revenue, by treatment, 2016 - 2026(USD Million)
      • 6.3.4. France
        • 6.3.4.1. France hunter syndrome treatment market revenue, by treatment, 2016 - 2026(USD Million)
      • 6.3.5. Germany
        • 6.3.5.1. Germany hunter syndrome treatment market revenue, by treatment, 2016 - 2026(USD Million)
      • 6.3.6.Rest of Europe
        • 6.3.6.1. Rest of Europe hunter syndrome treatment market revenue, by treatment, 2016 - 2026(USD Million)
    • 6.4. Asia Pacific
      • 6.4.1. Asia Pacific hunter syndrome treatment market, by country, 2016 - 2026(USD Million)
      • 6.4.2. Asia Pacific hunter syndrome treatment market revenue, by treatment, 2016 - 2026(USD Million)
      • 6.4.3. China
        • 6.4.3.1. China hunter syndrome treatment market revenue, by treatment, 2016 - 2026(USD Million)
      • 6.4.4. Japan
        • 6.4.4.1. Japan hunter syndrome treatment market revenue, by treatment, 2016 - 2026(USD Million)
      • 6.4.5. India
        • 6.4.5.1. India hunter syndrome treatment market revenue, by treatment, 2016 - 2026(USD Million)
      • 6.4.6. Rest of Asia Pacific
        • 6.4.6.1. Rest of Asia Pacific hunter syndrome treatment market revenue, by treatment, 2016 - 2026(USD Million)
    • 6.5. Latin America
      • 6.5.1. Latin America hunter syndrome treatment market, by country, 2016 - 2026(USD Million)
      • 6.5.2. Latin America hunter syndrome treatment market revenue, by treatment, 2016 - 2026(USD Million)
      • 6.5.3. Brazil
        • 6.5.3.1. Brazil hunter syndrome treatment market revenue, by treatment, 2016 - 2026(USD Million)
      • 6.5.4. Rest of Latin America
        • 6.5.4.1. Rest of Latin America hunter syndrome treatment market revenue, by treatment, 2016 - 2026(USD Million)
    • 6.6. Middle East & Africa
      • 6.6.1. Middle East & Africa hunter syndrome treatment market revenue, by treatment, 2016 - 2026(USD Million)
  • Chapter 7. Company Profiles
    • 7.1. GC Pharma
      • 7.1.1. Overview
      • 7.1.2. Financials
      • 7.1.3. Product Portfolio
      • 7.1.4. Business Strategy
      • 7.1.5. Recent Developments
    • 7.2. Takeda Pharmaceutical Company
      • 7.2.1. Overview
      • 7.2.2. Financials
      • 7.2.3. Product Portfolio
      • 7.2.4. Business Strategy
      • 7.2.5. Recent Developments
    • 7.3. RegenxBio Inc.
      • 7.3.1. Overview
      • 7.3.2. Financials
      • 7.3.3. Product Portfolio
      • 7.3.4. Business Strategy
      • 7.3.5. Recent Developments
    • 7.4. JCR Pharmaceuticals Co Ltd.
      • 7.4.1. Overview
      • 7.4.2. Financials
      • 7.4.3. Product Portfolio
      • 7.4.4. Business Strategy
      • 7.4.5. Recent Developments
    • 7.5. Sangamo Therapeutics, Inc.
      • 7.5.1. Overview
      • 7.5.2. Financials
      • 7.5.3. Product Portfolio
      • 7.5.4. Business Strategy
      • 7.5.5. Recent Developments
    • 7.6. Inventiva S.A.
      • 7.6.1. Overview
      • 7.6.2. Financials
      • 7.6.3. Product Portfolio
      • 7.6.4. Business Strategy
      • 7.6.5. Recent Developments
    • 7.7. ArmaGen Inc
      • 7.7.1. Overview
      • 7.7.2. Financials
      • 7.7.3. Product Portfolio
      • 7.7.4. Business Strategy
      • 7.7.5. Recent Developments
    • 7.8. Bioasis Technologies Inc.
      • 7.8.1. Overview
      • 7.8.2. Financials
      • 7.8.3. Product Portfolio
      • 7.8.4. Business Strategy
      • 7.8.5. Recent Developments
    • 7.9. Esteve
      • 7.9.1. Overview
      • 7.9.2. Financials
      • 7.9.3. Product Portfolio
      • 7.9.4. Business Strategy
      • 7.9.5. Recent Developments
    • 7.10. Denali Therapeutics Inc.
      • 7.10.1. Overview
      • 7.10.2. Financials
      • 7.10.3. Product Portfolio
      • 7.10.4. Business Strategy
      • 7.10.5. Recent Developments

Table Of Figures

List of Figures

1. Market research process
2. Market research methodology
3. Global hunter syndrome treatment market, 2016 - 2026(USD Million)
4. Porter’s five forces analysis: hunter syndrome treatment market
5. Global hunter syndrome treatment market attractiveness, by treatment
6. Global hunter syndrome treatment market revenue share, by treatment, 2019 and 2026
7. Global hunter syndrome treatment market by Hematopoietic Stem Cell Transplant (HSCT), 2016 - 2026(USD Million)
8. Global hunter syndrome treatment market by Enzyme Replacement Therapy (ERT), 2016 - 2026(USD Million)
9. Global hunter syndrome treatment market by Others, 2016 - 2026(USD Million)
10.  Global hunter syndrome treatment market revenue share, by region, 2018 & 2025
11.  North America hunter syndrome treatment market, 2016 - 2026(USD Million)
12.  Europe hunter syndrome treatment market, 2016 - 2026(USD Million)
13.  Asia Pacific hunter syndrome treatment market, 2016 - 2026(USD Million)
14.  Latin America hunter syndrome treatment market, 2016 - 2026(USD Million)
15.  Middle East & Africa hunter syndrome treatment market, 2016 - 2026(USD Million)


Table Of Tables

List of Tables

1. Global hunter syndrome treatment market: snapshot
2. Drivers for hunter syndrome treatment market: impact analysis
3. Restraints for hunter syndrome treatment market: impact analysis
4. North America hunter syndrome treatment market revenue, by country, 2016 - 2026(USD Million)
5. North America hunter syndrome treatment market revenue, by treatment, 2016 - 2026(USD Million)
6. The U.S. hunter syndrome treatment market revenue, by treatment, 2016 - 2026(USD Million)
7. Rest of North America hunter syndrome treatment market revenue, by treatment, 2016 - 2026(USD Million)
8. Europe hunter syndrome treatment market revenue, by country, 2016 - 2026(USD Million)
9. Europe hunter syndrome treatment market revenue, by treatment, 2016 - 2026(USD Million)
10.  U.K. hunter syndrome treatment market revenue, by treatment, 2016 - 2026(USD Million)
11. France hunter syndrome treatment market revenue, by treatment, 2016 - 2026(USD Million)
12. Germany hunter syndrome treatment market revenue, by treatment, 2016 - 2026(USD Million)
13. Rest of Europe hunter syndrome treatment market revenue, by treatment, 2016 - 2026(USD Million)
14. Asia Pacific hunter syndrome treatment market revenue, by country, 2016 - 2026(USD Million)
15. Asia Pacific hunter syndrome treatment market revenue, by treatment, 2016 - 2026(USD Million)
16. China hunter syndrome treatment market revenue, by treatment, 2016 - 2026(USD Million)
17. Japan hunter syndrome treatment market revenue, by treatment, 2016 - 2026(USD Million)
18. India hunter syndrome treatment market revenue, by treatment, 2016 - 2026(USD Million)
19. Rest of Asia Pacific hunter syndrome treatment market revenue, by treatment, 2016 - 2026(USD Million)
20. Latin America hunter syndrome treatment market revenue, by country, 2016 - 2026(USD Million)
21. Latin America hunter syndrome treatment market revenue, by treatment, 2016 - 2026(USD Million)
22. Brazil hunter syndrome treatment market revenue, by treatment, 2016 - 2026(USD Million)
23. Rest of Latin America hunter syndrome treatment market revenue, by treatment, 2016 - 2026(USD Million)
24. Middle East & Africa hunter syndrome treatment market revenue, by treatment, 2016 - 2026(USD Million)
 

Methodology

FrequentlyAsked Questions

Hunter syndrome, commonly known as mucopolysaccharidosis II (MPS II), is a rare genetic condition characterized by iduronate-2-sulfatase deficiency. This deficit causes glycosaminoglycans to accumulate in cells, creating a variety of progressive and debilitating symptoms.
 

The global demand for hunter syndrome treatment market is driven by expected approval of new therapies, growing research and development activities, and extended life expectancy.

Global Hunter Syndrome Treatment market size earned around $1175.86 Mn in 2023 and is expected to reach $2,331.03 Mn by 2032, with a projected CAGR of 7.9%.

North America held largest revenue share of the global hunter syndrome treatment market in 2023. This large share is attributed to government funding, growing awareness and presence of key players in this region. 

Major players in hunter syndrome treatment market are GC Pharma, Takeda Pharmaceutical Company, RegenxBio Inc., JCR Pharmaceuticals Co Ltd., Sangamo Therapeutics, Inc., Inventiva S.A., ArmaGen Inc, Esteve, Bioasis Technologies Inc., and Denali Therapeutics Inc among others.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed